Furthermore, the amount of tau protein in human cerebrospinal fluid (CSF), independently of Aβ, is a relatively strong predictor of progression of AD or cognitive decline (Jagust, 2013; Kandimalla et al., 2013; Wirth et al., 2013; Koch et al., 2014). The gene discussed is MAPT; the disease is Alzheimer disease.